Medlive Technology Co
Medlive Technology Co., a leading player in the healthcare technology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in medical data solutions, telemedicine, and healthcare management systems. Medlive's core offerings include advanced medical imaging software and integrated health information platforms, designed to enhance clinical decision-making and improve patient outcomes. What sets Medlive apart is its commitment to innovation, leveraging cutting-edge technology to streamline healthcare processes. With a strong market position, Medlive Technology Co. has achieved significant milestones, including partnerships with major healthcare institutions and recognition for its contributions to digital health. The company continues to drive advancements in the industry, making healthcare more accessible and efficient for providers and patients alike.
DitchCarbon Score
How does Medlive Technology Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medlive Technology Co's score of 28 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medlive Technology Co's reported carbon emissions
In 2023, Medlive Technology Co, headquartered in CN, reported significant carbon emissions, totalling approximately 768,176,000 kg CO2e from Scope 3 sources and about 60,102,000 kg CO2e from Scope 2 emissions. Notably, the company recorded no emissions from Scope 1. Comparatively, in 2022, Medlive's Scope 2 emissions were about 67,758,000 kg CO2e, while Scope 1 emissions remained at zero. The trend indicates a slight reduction in Scope 2 emissions from 2022 to 2023. However, there is no disclosed data on Scope 3 emissions for 2022, making it challenging to assess year-on-year changes in that category. Despite these figures, Medlive Technology Co has not established specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. This lack of formal commitments may reflect broader industry trends where companies are increasingly pressured to disclose and act on their carbon footprints.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | - |
| Scope 2 | 67,396,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medlive Technology Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
